Correction to: Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands

Renée Else Michels, Maria Francesco, Koshu Mahajan, Gerald J. D. Hengstman, Krijn M. H. Schiffers, Sangeeta Budhia, Gerard Harty and Marieke Krol ()
Additional contact information
Renée Else Michels: IQVIA, Real World Evidence Solutions
Maria Francesco: IQVIA, Real World Insights
Koshu Mahajan: IQVIA, Real World Insights
Gerald J. D. Hengstman: Catharina Hospital
Krijn M. H. Schiffers: Merck B.V.
Sangeeta Budhia: PAREXEL International, PAREXEL Access Consulting
Gerard Harty: EMD Serono, a business of Merck KGaA
Marieke Krol: IQVIA, Real World Evidence Solutions

Applied Health Economics and Health Policy, 2020, vol. 18, issue 1, No 13, 141 pages

Abstract: The second author’s name should be “Maria De Francesco” rather than “Maria de Fransesco”.

Date: 2020
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40258-019-00548-6 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:aphecp:v:18:y:2020:i:1:d:10.1007_s40258-019-00548-6

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40258

DOI: 10.1007/s40258-019-00548-6

Access Statistics for this article

Applied Health Economics and Health Policy is currently edited by Timothy Wrightson

More articles in Applied Health Economics and Health Policy from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().